Brigatinib powder

What is BrigatinibPowder ?

Brigatinib powder is a substance that contains the active pharmaceutical ingredient brigatinib, which is a targeted therapy medication used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC). It works by interfering with the growth and spread of cancer cells in the body. Brigatinib powder may be used to prepare oral suspensions or other formulations for administration to patients.

Why Choose Us?

Salispharm stands out as the Brigatinib powder supplier of this product due to several key advantages:

1. Mature R&D Team: We have a committed group of specialists who ceaselessly make progress toward development and greatness in drug natural substances.

2. GMP Factory: Our assembling office sticks to Great Assembling Practices (GMP), guaranteeing the best expectations of value and wellbeing underway.

   

    

3. Large Inventory: We keep an enormous stock of this product to satisfy orders instantly and proficiently.

4. Complete Certificates: Our items are joined by all important endorsements, including FDA-Salis, HALAL, ISO, CCRE5, natural USDA, natural, and EU Natural accreditations, guaranteeing consistence with worldwide quality norms.

5. OEM Service: We offer OEM administrations, empowering clients to tweak dose structures as indicated by their particular prerequisites. We can likewise aid the creation and offer of completed items.

6. Fast Delivery: We focus on quick conveyance to limit lead times and guarantee ideal admittance to our items.
   Secure Packaging: Our items are firmly stuffed to forestall tainting and keep up with item honesty during transportation.

COA

Drug Use

Brigatinib is a medication that falls into the category of anticancer drugs, particularly targeted therapy for the treatment of non-small cell lung cancer (NSCLC). It is used primarily in patients who have been diagnosed with metastatic NSCLC that has specific mutations, such as anaplastic lymphoma kinase (ALK) gene alterations. Brigatinib works by inhibiting the activity of the ALK protein, which can help slow down or stop the growth of cancer cells.

The application of brigatinib is focused on treating NSCLC where other treatments have not been successful or when the cancer has spread to other parts of the body. It is usually provided in the form of oral tablets or can be prepared from brigatinib powder for oral suspension, and it's typically recommended for patients who have previously received ALK inhibitor therapy.

Brigatinib is an important option in the treatment of certain types of NSCLC, offering a targeted approach to combat the specific genetic mutations that drive the growth of cancer. However, it is important to note that the use and application of brigatinib should always be guided by a healthcare professional, and patients should be closely monitored for potential side effects and treatment responses.

Application Areas

Brigatinib, also known as AP-26113, is an orally active, potent and selective Dual ALK/EGFR inhibitor. AP26113 binds to and inhibits ALK kinase and ALK fusion proteins as well as EGFR and mutant forms. This leads to the inhibition of ALK kinase and EGFR kinase, disrupts their signaling pathways and eventually inhibits tumor cell growth in susceptible tumor cells. In addition, AP26113 appears to overcome mutation-based resistance. ALK belongs to receptor superfamily and plays an important role in nervous system development; ALK dysregulation and gene rearrangements are associated with a series of tumors. EGFR is overexpressed in a variety of cancer cell types.

Dosage and Usage

The dosage and usage of brigatinib can vary depending on the specific medical condition and individual patient factors. However, the typical recommended dosage of brigatinib for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) is 90 mg to be taken orally once daily.

Quality Standards and Certification

Salispharm's product meets the highest quality standards and is accompanied by the following certifications:

1. FDA-Salis
2. HALAL
3. ISO
4. CCRE5
5. Organic USDA
6. Organic
7. EU Organic

These certifications ensure that our products comply with international regulations and requirements for pharmaceutical raw materials.

Packaging and Transportation

We package our Brigatinib powder securely to ensure its safety and integrity during transportation. Our packaging is designed to prevent contamination and maintain product quality throughout the supply chain. We utilize durable materials and employ proper sealing techniques to safeguard the product from external factors.

FAQ

1. Who are we?
We are based in Xian, China, start from 2020,sell to Domestic Market(45.00%),Western Europe(10.00%),EasternAsia(10.00%),North America(10.00%),Africa(5.00%),Central America(5.00%),Southeast Asia(5.00%),South America(5.00%),Mid East(5.00%). There are total about 51-100 people in our office.
2. How can we guarantee quality?
Always a pre-production sample before mass production; Always final Inspection before shipment;
3. What can you buy from us?
Fluorescent whitening agents, pigments and dyes, pharmaceutical intermediates, paint decoration, pharmaceutical impurities and other products.
4.Why should you buy from us not from other suppliers?
RD &marketing experience products are exported to Europe, North and South America, the Middle East, Asia Pacific and Africa area, so as to establish a long-term and stable cooperation relationship with customer in the world.
5.What services can we provide?
Accepted Delivery Terms: FOB,CFR,CIF,EXW,FAS,CIP,CPT,DDU,Express Delivery; Accepted Payment Currency:USD,EUR,CNY; Accepted Payment Type: T/T,L/C,D/P D/A,Western Union,Cash; Language Spoken:English,Chinese.

Contact Us

We are focused on gathering our clients' different requirements and offering astounding assistance. For additional data on our items and valuing, If you want to buy Brigatinib powder Powder, please feel free to reach us at sasha_slsbio@aliyun.com. Our group is prepared to help you with any requests and give fitted answers for suit your prerequisites.